ARC-IM restores Parkinson's Disease mobility imbalances
ONWARD reported a Nature publication showing the FiH of ARC-IM in Parkinson's Disease addressing mobility improvement. While it is not a near-term focus indication, the groundbreaking results not only prove ONWARD as the next-gen neuromodulation innovator but also further validate ARC Therapy as a
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.